Julie Gerberding, MD, FIDSA, has been named president of Merck Vaccines. Dr. Gerberding was the director for the Centers for Disease Control and Prevention (CDC) from 2002 to 2009. She previously served as a member of the IDSA Annual Meeting Program Committee and the IDSA Emerging Infections Network Committee. A member of the Institute of Medicine and a fellow of the American College of Physicians, Dr. Gerberding is also a clinical professor of infectious diseases at Emory University and an adjunct associate professor of medicine in infectious diseases at the University of California in San Francisco.
Richard T. Kenney, MD, FIDSA, has been appointed vice president of clinical development at Vical Inc. Dr. Kenney previously worked at GSK Biologicals as the senior director of global clinical R&D, vaccines for viral diseases. He is also a fellow of the American College of Physicians and a member of several professional organizations, including the American Federation for Medical Research and the American Society of Tropical Medicine and Hygiene.
Are you a member on the move? Do you know someone who is? Contact Stephanie Cox at firstname.lastname@example.org so that we can announce it to our membership.
< Previous Article | Next Article >